article · Archivos Españoles de Urología
OBJECTIVE: To assess the stone-free rate (SFR) and safety of our new modified technique of mini-percutaneous nephrolithotomy (mini-PCNL) using counter-irrigation through a separate upper pole access. METHODS: The medical data of 40 patients with kidney stones (<30 mm) and a dilated upper calyx treated with our novel modification of mini-PCNL between August 2020 and October 2021 were prospectively collected and analysed. Stone-free status of the patients was evaluated at 3 days and 1 month post-operatively via abdominal and pelvic non-contrast computed tomography (NCCT). RESULTS: The mean stone size was 24.68 ± 2.86 mm, and the mean stone density was 931.38 ± 308.92 hounsfield unit (HU). The mean total operative time was 78.8 ± 13.62 min, while the mean time required for placing the upper calyceal nephrostomy tube was 3.76 ± 1.25 min. Immediate overall SFR was 90%, which reached 95% at the 1-month follow-up. The overall complication rate was 10% (four patients), including fever (38 °C) that required antipyretics in two (5%), fever (38 °C) that necessitated hydration and IV antibiotics in one (2.5%), and persistent mild haematuria that improved with coagulants and excess fluid intake in one (2.5%). CONCLUSIONS: Counter-irrigation in mini-PCNL for a renal pelvic stone with a dilated upper calyx is an encouragingly safe and effective option. This novel technique provides a potentially high SFR and acceptable safety profile via enhanced intra-operative visualisation, decreased stone migration, and better washout of stone fragments.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.56434/j.arch.esp.urol.20257801.2
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.